Charles Fisher On Raising $70 Million To Help Develop Drugs More Ethically
Charles Fisher’s AI startup has attracted some significant capital as it works to speed up solutions for both pharma companies, and their patients. His venture, Unlearn, has attracted funding from top-tier investors like Mubadala Capital Ventures, Insight Partners, Radical Ventures, and DCVC Bio.
DealMakers: Entrepreneur | Startups | Venture Capital
Audio is streamed directly from the publisher (injector.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Charles Fisher’s AI startup has attracted some significant capital as it works to speed up solutions for both pharma companies, and their patients. His venture, Unlearn, has attracted funding from top-tier investors like Mubadala Capital Ventures, Insight Partners, Radical Ventures, and DCVC Bio.